Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19

Objective: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Renin-angiotensin-aldosterone-system (RAAS) inhibitors may increase the expression of angiotensin-converting enzyme 2, which is the receptor for SARSCoV-2 Spike protein. The...

Full description

Bibliographic Details
Main Authors:	Naci Şenkal, Rasimcan Meral, Alpay Medetalibeyoğlu, Hilal Konyaoğlu, Murat Kose, Tufan Tukek
Format:	Article
Language:	English
Published:	KARE Publishing 2020-07-01
Series:	Anatolian Journal of Cardiology
Subjects:	coronavirus disease 2019 angiotensin-converting enzyme 2 angiotensin ii receptor type 1 blockers angiotensin-converting enzyme inhibitors
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-57431

Similar Items

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
by: Brini, M., et al.
Published: (2022)

Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
by: Xiao-Ce Dai, et al.
Published: (2021-04-01)

2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications
by: Luigi Cappannoli, et al.
Published: (2020-12-01)

Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality
by: Malindu E. Fernando, et al.
Published: (2021-09-01)

ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
by: David S. Weisman, et al.
Published: (2020-01-01)

Angiotensin-converting enzyme inhibitors or sartans in patients at high risk for cardiovascular events: a wrong question or an undesirable answer
by: S R Gilyarevsky, et al.
Published: (2013-03-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

From gene to protein - experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
by: Sheila K Patel, et al.
Published: (2014-06-01)

A high sodium intake reduces antiproteinuric response to renin–angiotensin–aldosterone system blockade in kidney transplant recipients
by: Elena Monfá, et al.
Published: (2016-09-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Inhibition of Angiotensin Converting Enzyme Impairs Anti-staphylococcal Immune Function in a Preclinical Model of Implant Infection
by: Rishi Trikha, et al.
Published: (2020-09-01)

Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
by: S Bhuvaneshwari, et al.
Published: (2018-07-01)

Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse
by: Heleia Roca-Ho, et al.
Published: (2017-03-01)

Pulmonary midkine inhibition ameliorates sepsis induced lung injury
by: Jing-Yuan Xu, et al.
Published: (2021-02-01)

Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth
by: Kunal Bikram Shaha, et al.
Published: (2020-05-01)

The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience
by: S R Gilyarevsky
Published: (2014-06-01)

Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis
by: Qiong Ling, et al.
Published: (2018-02-01)

Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
by: M. E. Ougaard, et al.
Published: (2018-10-01)

ACE2 Attenuates Epithelial-Mesenchymal Transition in MLE-12 Cells Induced by Silica
by: Li S, et al.
Published: (2020-04-01)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014-01-01)

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
by: Philip Braude, et al.
Published: (2020-12-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Increased angiotensin-converting enzyme activity in the left ventricle after infarction
by: V.C.W. Busatto, et al.
Published: (1997-05-01)

Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension
by: A A Khadartsev, et al.
Published: (2017-12-01)

COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system
by: Jaejin An, et al.
Published: (2021-06-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
by: Mishita Goel, et al.
Published: (2020-08-01)

Skin Reactions with Losartan and Enalapril in Cardiac Patients
by: Fariba Iraji, et al.
Published: (2012-03-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)

A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity
by: M.F. Alves, et al.
Published: (2005-06-01)

COVID-19: a hypothesis regarding the ventilation-perfusion mismatch
by: Mario G. Santamarina, et al.
Published: (2020-07-01)

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
by: Melissa Y. Y. Moey, et al.
Published: (2019-07-01)

Decreased Plasma Levels of Angiotensin-Converting Enzyme Among Patients With Bipolar Disorder
by: Marsal Sanches, et al.
Published: (2021-02-01)

Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
by: Gabriela M. Silva, et al.
Published: (2020-09-01)

IS IT WORTH TO DISCONTINUE DRUGS BLOCKING THE ACTIVITY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PERI-OPERATIVE PERIOD?
by: V. V. Lomivorotov, et al.
Published: (2018-07-01)

Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA)
by: K. G Pereverzeva, et al.
Published: (2017-09-01)

Angiotensin-Converting Enzymes Play a Dominant Role in Fertility
by: Fan Jin, et al.
Published: (2013-10-01)

Attenuation of Myocardial Fibrosis with Curcumin Is Mediated by Modulating Expression of Angiotensin II AT1/AT2 Receptors and ACE2 in Rats [Corrigendum]
by: Pang X, et al.
Published: (2020-06-01)

Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma
by: Archika Gupta, et al.
Published: (2021-01-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)